Sentence examples for mechanisms thereof from inspiring English sources

We discuss the regenerative potential and the molecular mechanisms thereof, in the zebrafish spinal cord, retina, optic nerve and higher brain centres.

Despite the successes in reactivating TD cells and elucidating the mechanisms thereof, inducing proliferation of TD cells remains unfeasible.

Future studies may be necessary to evaluate the relationship of vitamin D deficiency to stroke outcomes and the mechanisms thereof.

For this reason, the understanding of gene expression profiles, which provide signatures of all the active genes and their interconnections in a cell, contain valuable information about the functioning of key pathways, as expressed by the hallmarks of cancer and, hence, enable a practical investigation of functional mechanisms thereof [ 28- 36].

To evaluate the effects of a high-fat diet on cancer development and progression and the underlying mechanisms thereof, we used the 4T1 orthotopic model, in which 4T1 mammary carcinoma cells are injected into the mammary fat pads of immune-competent BALB/c mice.

The total process and the mechanism thereof were verified based on DFT and coupled cluster (CC) calculations.

Sepsis-induced cardiac dysfunction may limit fluid responsiveness and the mechanism thereof remains unclear.

It is also worth noting that the incorporation of either H-thymidine or BrdU can only be interpreted as DNA synthesis but not as a particular mechanism thereof.

To illustrate the participation of RanBP2 in cell-cycle regulation and to understand the underlying molecular mechanism thereof, we examined the effects of modulating RanBP2 expression on cell-cycle progression.

The differences in compensating mechanisms, or lack thereof, will likely reflect the relative content of haplosufficient vs. haploinsufficient genes on the sex chromosomes, but will also reflect early events of sex chromosome evolution, outcomes of sexual selection and sexual conflict, and the life history of the organism [ 11].

One critic argues, 'given that biomarker support of mechanism, or lack thereof, has not contributed to go/no-go decisions in practice, sponsors should reconsider the value of including any biomarker evaluations in phase I oncological studies' (Ratain and Glassman, 2007).